Post-earnings recap
Reported
Wed, Jan 23, 2008
Est. EPS
—
Est. revenue
—
Implied move
—
EPS beat rate
100%
Abbott Laboratories reported an EPS of $0.93, slightly beating expectations. The stock reacted positively, increasing by 0.69%. However, without revenue figures or management commentary, it's difficult to assess the broader implications of the results.
| Metric | Actual | Expected | Surprise |
|---|---|---|---|
| EPS | $0.93 | N/A | +1.31% |
| Revenue | N/A | N/A | N/A |
No transcript is on record for the earnings call, so the analysis is based solely on numerical results.
—
Est. EPS
—
Est. Rev
—
Impl. Move
—